Yes, addiction is classified as a mental illness. Both major diagnostic systems used worldwide place it squarely within their mental health chapters. The DSM-5-TR, the standard reference for psychiatric diagnoses in the United States, lists substance use disorders alongside conditions like depression, anxiety, and schizophrenia. The World Health Organization’s ICD-11 classifies addiction under “Mental, Behavioral, and Neurodevelopmental Disorders.” This isn’t a gray area or a matter of opinion among clinicians. It is a recognized psychiatric condition with defined diagnostic criteria, known biological mechanisms, and evidence-based treatments.
How Addiction Is Formally Diagnosed
The DSM-5-TR treats addiction as a spectrum. It combined older categories of “substance abuse” and “substance dependence” into a single diagnosis called substance use disorder, measured on a continuum from mild to severe. A clinician evaluates 11 possible symptoms, and meeting just two or three of them qualifies as a mild substance use disorder. More symptoms indicate moderate or severe forms. Each substance gets its own specific diagnosis (alcohol use disorder, opioid use disorder, stimulant use disorder), but nearly all are evaluated using the same set of criteria.
Those 11 symptoms fall into four broad categories. Impaired control covers cravings, failed attempts to cut back, and using more than intended. Social problems include neglecting responsibilities at work, school, or home. Risky use means continuing despite physical danger or worsening health. Physiological signs include tolerance (needing more to get the same effect) and withdrawal symptoms when stopping. Craving, notably, was added as a diagnostic criterion in the current edition, reflecting how central that experience is to the condition.
What Changes in the Brain
Addiction reshapes the brain’s reward, motivation, and decision-making systems. The core mechanism involves dopamine, a chemical messenger that signals pleasure and importance. When someone uses a substance repeatedly, the brain’s dopamine receptors decrease in number, particularly in areas responsible for evaluating what matters and controlling impulses. Brain imaging studies show that people with addiction have lower receptor levels in the reward center, paired with reduced baseline activity in the frontal brain regions that handle judgment, decision-making, and self-control.
This combination creates a specific pattern: ordinary rewards (food, relationships, accomplishments) register as less compelling, while substance-related cues become disproportionately powerful. Over time, even encountering reminders of drug use, like a familiar place or a certain social situation, triggers dopamine surges in the part of the brain responsible for habit formation. The strength of that surge directly correlates with how intense the craving feels. What starts as a voluntary choice becomes increasingly automatic, driven by the same brain circuits that govern deeply ingrained habits.
Beyond dopamine, repeated drug use triggers changes across multiple chemical systems involved in stress response, memory, and emotional regulation. These widespread neurological shifts are a key reason major medical organizations treat addiction as a chronic condition rather than a temporary lapse in willpower.
Genetics Account for Roughly Half the Risk
Research estimates that 40% to 60% of a person’s vulnerability to developing a substance use disorder is hereditary. That means genetics contribute about as much risk as all environmental factors combined, including trauma, peer influence, stress, and drug availability. No single gene determines whether someone becomes addicted. Instead, many genes each contribute a small amount of risk, affecting things like how intensely a person experiences a drug’s effects, how quickly they metabolize substances, and how their stress response systems function.
This genetic contribution is comparable to what researchers see in other chronic conditions like heart disease and type 2 diabetes. Having a family history doesn’t guarantee someone will develop an addiction, but it meaningfully raises the odds, especially when combined with environmental triggers.
Why Some Experts Push Back on “Brain Disease”
While the clinical classification is settled, there is genuine scientific debate about how to describe addiction’s underlying nature. The American Society of Addiction Medicine defines it as “a treatable, chronic medical disease involving complex interactions among brain circuits, genetics, the environment, and an individual’s life experiences.” This brain disease framing was originally developed both as an explanatory model and as a tool to reduce stigma.
Critics, including some researchers publishing in The Lancet Psychiatry, argue the brain disease model has weak empirical support in certain respects and downplays the psychosocial causes of addiction: poverty, trauma, social isolation, lack of opportunity. Their concern isn’t that addiction is imaginary or purely a choice. Rather, they argue that focusing too narrowly on brain changes can obscure the environmental conditions that drive substance use in the first place. Part of the disagreement stems from the fact that there’s no universally agreed-upon definition of what makes something a “brain disease” versus a mental disorder that happens to involve the brain (as all mental activity does).
In practical terms, this debate matters less than it might seem. Both sides agree that addiction involves real changes in brain function, that it has genetic and environmental roots, that it impairs a person’s ability to make free choices about substance use, and that it responds to treatment. The disagreement is more about framing than about whether people with addiction deserve medical care.
How It Differs From Simply Making Bad Choices
The distinction between addiction and voluntary behavior shows up clearly in how it affects daily functioning. The American Psychiatric Association describes substance use disorder as a condition involving “distorted thinking and behaviors” driven by structural and functional changes in the brain. People with addiction experience personality shifts, impaired judgment, and altered decision-making not because they lack moral character, but because the brain systems responsible for weighing consequences and controlling impulses are physically operating differently.
Initial drug use is typically voluntary. But as the condition progresses, the ability to choose not to use becomes increasingly compromised. This trajectory, where behavior starts as a choice and becomes compulsive, is a hallmark of addiction that separates it from casual or recreational substance use. A person who can decide to stop drinking after two beers is in a fundamentally different neurological situation than someone whose brain has been reshaped by years of heavy alcohol use.
Treatment Looks Like Treatment for Other Chronic Conditions
Because addiction is classified as a chronic medical condition, its treatment follows similar principles to managing diseases like asthma or hypertension: ongoing care, relapse prevention, and a combination of approaches tailored to the individual. The American Society of Addiction Medicine notes that prevention efforts and treatment outcomes for addiction are generally as successful as those for other chronic diseases.
Treatment typically involves some combination of counseling (outpatient or inpatient), behavioral therapy, and in some cases medication. Counseling helps people identify their triggers and understand the patterns driving their use. For opioid use disorder specifically, medications that reduce cravings and withdrawal symptoms are often the first line of treatment. These medications help people stay in treatment longer and significantly reduce the risk of overdose.
Inpatient rehabilitation provides a structured, substance-free environment for people who need more intensive support. Outpatient options, including telehealth, work well for others. Many people benefit from treating co-occurring mental health conditions at the same time, since addiction frequently overlaps with depression, anxiety, and trauma-related disorders. The ICD-11 formally recognizes these substance-induced mental health conditions, including mood disorders, anxiety disorders, and impulse control disorders that develop during or after substance use.
Recovery is not a single event but an ongoing process. Like other chronic conditions, addiction can involve setbacks, and a relapse doesn’t mean treatment has failed. It means the treatment plan needs adjusting.